Your hindsight isn't 20/20. Perhaps an on staff seer could have led them to do a financing before the FDA slapped a hold on C717. I can't even imagine the howling you would have done had they "sucked it up with R&R". There was nothing BS about the "ADHD route" when they launched those trials. NOBODY thought that was a bad idea AT THAT TIME. The financings done have brought us here, still afloat. The only partnerships available in the last three years would have had horrible terms.
I get that you're frustrated. I just don't see management as its cause.